VOTE THE WHITE PROXY TODAY
The Bristol-Myers Squibb Board of Directors unanimously recommends that Bristol-Myers Squibb shareholders vote “FOR” the approval of the issuance of shares of the Company’s common stock in the merger with Celgene on the WHITE proxy card.
Every vote matters. If a Bristol-Myers Squibb shareholder does not vote or instruct their broker as to how they want to vote, their shares will not be counted.
To support Bristol-Myers Squibb, shareholders can vote using the WHITE proxy card or WHITE voting instruction form(s) they receive in the mail. It is important that shareholders vote on the WHITE proxy card or WHITE voting instruction form that they receive for each of their accounts.
Bristol-Myers Squibb shareholders can vote their shares by mail, online or by phone.
Bristol-Myers Squibb shareholders who have questions or would like additional information should contact the firm assisting Bristol-Myers Squibb in the solicitation of proxies:
MacKenzie Partners, Inc.
Phone: Toll-free in the U.S. at +1 (800) 322-2885 or Toll/International at + 1 (212) 929-5500